Delivery Order SPE2DB20D3103-SPE2DB23FM5T7
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,420.21, is for the delivery of 4563424797 - Sodium Phosphate 45 MMOL/15 ML 15ML. It is a firm fixed-price contract with a performance period running through January 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,254.28, is for the delivery of sodium phosphate 45 mmol/15 ml in 15 ml vials. The award has an ultimate completion date of August 11, 2023, and is a firm fixed-price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a federal delivery order contract awarded by the U.S. Department of Defense's Defense Logistics Agency (DLA) to the Corporate Office Division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of sodium phosphate 45 mmol/15 ml in 15 ml vials, with a ceiling value of $14,180.29 and a period of performance through April 2024. The contract is a firm fixed-price delivery order placed under Amerisourcebergen's existing Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,179.34 fixed-price delivery order is for the supply of sodium phosphate, a medical product used in various healthcare applications. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB23FP1Q7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,500.22, is for the delivery of 4561635010 - Sodium Phosphate 15 MMOL/5 ML 5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 31, 2023. Amerisourcebergen Drug Corp holds significant...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX6VP, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4563063274 - SODIUM PHOSPHATE 15 MMOL/5 ML 5ML, with a ceiling value of $3,415.90 and a completion date of December 12, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4563363535 - SODIUM PHOSPHATE 45 MMOL/15 ML 15ML, with a potential value of $1,356.10 and a completion date of January 22, 2024. The contract has no set-aside designation. Amerisourcebergen Drug Corp, through its...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563363537 - SODIUM PHOSPHATE 45 MMOL/15 ML 15ML. The $1,356.10 order has a completion date of January 22, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor providing pharmaceutical products and medical supplies to support DLA Troop Support Medical programs and facilities. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,666.72 firm fixed-price delivery order is for the supply of 4,561,306,734 units of 15 mmol/5 ml sodium phosphate solution. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as...
- This is a delivery order (SPE2DB22FL7G9) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of "SODIUM PHOSPHATE 3MM/ML VIAL 15ML". The contract has a ceiling value of $1,244.91 and runs through November 23, 2021. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a separate Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FM5T7Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,716.09, is for the provision of 4560051498 - Sodium Phosphate 45 mmol/15 ml, 15 ml. The contract is a firm fixed-price delivery order with a completion date of February 27, 2023. This contract is not associated with any set-aside designation, indicating it was a full and open competition. Amerisourcebergen, a for-profit organization, is a critical vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 2/24/23 |